Loading field map
For nearly three centuries, addiction has been explained in radically different ways: as a moral failing, a brain disease, a learned habit, or a symptom of social inequality. Each explanation carries consequences for who is blamed, what treatment looks like, and whether society should punish or help. The history of addiction science is the story of these competing frameworks—how they emerged, clashed, borrowed from each other, and continue to shape research and policy today.
The earliest systematic framework in the West was the Moral Model, dominant from the 1700s into the mid-1800s. It viewed addiction as a voluntary moral failure—a sin or character defect. The proper response was punishment, religious reform, or temperance. This framework aligned with religious and legal institutions and placed responsibility squarely on the individual.
The first major challenge came from the Disease Model, often traced to physician Benjamin Rush's 1784 pamphlet on the effects of alcohol. Rush argued that habitual drunkenness was a disease, not a moral choice—a medical condition requiring treatment. This reframing shifted the locus of responsibility from character to biology. The Disease Model gained traction through the 19th and 20th centuries, especially with the founding of Alcoholics Anonymous in 1935, which adopted the idea of addiction as a chronic, progressive disease. Unlike the Moral Model, the Disease Model offered a path to recovery through medical intervention and spiritual surrender, but it still located the problem inside the individual. The two frameworks coexisted in tension: the Moral Model persisted in legal and public discourse, while the Disease Model became the dominant clinical and institutional framework.
Around 1900, new frameworks broadened the field beyond individual pathology. The Psychological Model emerged from psychoanalysis and later behaviorism. It treated addiction as a symptom of underlying psychological conflict or as a learned behavior reinforced by reward. This model opened the door to psychotherapy and cognitive-behavioral interventions, directly challenging the Disease Model's purely biological focus. The Psychological Model itself evolved: early psychoanalytic accounts gave way to behavioral and cognitive explanations, and eventually to the Social Learning Model (1960s), which emphasized that addictive behaviors are learned through observation, modeling, and social reinforcement. The Social Learning Model narrowed the Psychological Model's scope by specifying mechanisms of acquisition and maintenance, and it provided a bridge to later cognitive-behavioral treatments.
At the same time, two frameworks shifted attention from the individual to the environment. The Public Health Model (1900s) applied the classic agent-host-environment triad: the addictive substance (agent), the individual's vulnerability (host), and the social and physical context (environment). This framework made prevention and regulation central—controlling availability, pricing, and marketing. The Sociocultural Model (1900s) focused on how cultural norms, social inequality, and community structures shape addiction rates. It argued that addiction is not just an individual problem but a product of social conditions. These two models are closely related but distinct: the Public Health Model emphasizes population-level interventions and epidemiological patterns, while the Sociocultural Model digs into cultural meaning and structural inequality. Both challenged the Disease Model's individualistic focus, arguing that addiction cannot be understood or treated without addressing social context.
The Neurobiological Model (1970s) deepened the Disease Model's biological claims by specifying brain circuits, neurotransmitters, and genetic factors. Advances in brain imaging allowed researchers to map addiction as a chronic brain disease involving reward, motivation, and memory systems—including mechanisms such as reward sensitization, where repeated drug use alters neural pathways to make the substance more desirable. This framework gave the Disease Model new scientific authority and became dominant in research funding and public discourse. However, it also narrowed the focus to neurochemistry, sometimes sidelining psychological and social factors.
The Biopsychosocial Model (1977, George Engel) was a direct response to this narrowing. In addiction science, it commits to integrating biological vulnerability (genetics, neurobiology), psychological factors (coping, motivation, trauma), and social context (environment, culture, policy). It is not merely a vague umbrella; it insists that no single level of analysis is sufficient and that effective treatment must address all three. This model has been influential in clinical training and holistic treatment programs, but it has struggled to guide specific research designs because it is difficult to operationalize all levels simultaneously.
Two frameworks emerged from grassroots and lived-experience movements. The Harm Reduction Model (1980s) arose during the HIV/AIDS crisis, when activists argued that demanding abstinence was unrealistic and deadly. Instead, it focused on reducing the negative consequences of drug use—needle exchanges, safe injection sites, opioid substitution therapy—without requiring cessation. This directly challenged the Disease Model's emphasis on abstinence as the only goal. Harm Reduction shares the Public Health Model's population focus but differs in its pragmatic, non-judgmental stance and its willingness to accept continued use. It remains in living disagreement with abstinence-oriented frameworks.
The Recovery Model (1990s) originated in the broader mental health recovery movement. It shifts the goal from symptom elimination to supporting a meaningful life, even if addiction persists. Unlike the Disease Model, which often frames addiction as a chronic condition requiring lifelong management, the Recovery Model emphasizes personal agency, hope, and peer support. It overlaps with the Psychological Model's focus on the individual but differs by centering lived experience and self-defined recovery rather than clinical cure.
Today, no single framework dominates. The Neurobiological Model leads in research funding and public messaging (e.g., "addiction is a chronic brain disease"). The Disease Model remains influential in clinical settings and mutual-help groups like AA. The Psychological Model, especially cognitive-behavioral and motivational interviewing approaches, is the backbone of most evidence-based treatments. The Public Health Model guides prevention and policy (e.g., tobacco control, opioid prescribing guidelines). The Sociocultural Model informs health equity research and critiques of the war on drugs. Harm Reduction has gained mainstream acceptance in many countries, though it remains controversial in the U.S. The Recovery Model shapes peer support services and recovery-oriented systems of care.
The sharpest disagreements today are between the Neurobiological/Disease Model and the Harm Reduction/Sociocultural cluster. The former sees addiction as a brain disease requiring medical treatment and often abstinence; the latter sees it as a social and behavioral phenomenon where reducing harm is more realistic and humane. The Biopsychosocial Model attempts to bridge these camps but is often invoked rhetorically rather than implemented. There is growing agreement that addiction is multifactorial and that no single framework explains all cases, but the field remains divided over whether the brain disease label is helpful or stigmatizing, and whether abstinence should be the default goal.